Y. Byun et al., EFFECT OF FIBRONECTIN ON THE BINDING OF ANTITHROMBIN-III TO IMMOBILIZED HEPARIN, Journal of biomedical materials research, 30(1), 1996, pp. 95-100
An objective of this research is to verify the mechanism of anticoagul
ant activity of surface-immobilized heparin in the presence of plasma
proteins. The competition and binding interaction between immobilized
heparin and antithrombin III (ATIII)/thrombin have been described in v
itro. However, the strong ionic character of heparin leads to its spec
ific and nonspecific binding with many other plasma proteins. Most not
ably, fibronectin contains six active binding sites for heparin which
may interfere with the subsequent binding of heparin with ATIII or thr
ombin. Heparin was covalently immobilized through polyethylene oxide (
PEG) hydrophilic spacer groups onto a model surface synthesized by ran
dom copolymerization of styrene and p-aminostyrene. The binding intera
ction of immobilized heparin with ATIII was then determined in the pre
sence of different fibronectin concentrations. The binding interaction
was studied by first binding immobilized heparin with ATIII, followed
by the introduction of fibronectin; heparin binding with fibronectin,
followed by incubation with ATIII, and simultaneous incubation of sur
face immobilized heparin with ATIII and fibronectin. The extent of ATI
II binding to heparin in each experiment was assayed using a chromogen
ic substrate for ATIII, S-2238. The results of this study demonstrate
that the displacement of ATIII from immobilized heparin was proportion
al to the fibronectin concentration, and was reversible. Furthermore,
the binding sequence did not play a role in the final concentration of
ATIII bound to immobilized heparin. (C) 1996 John Wiley & Sons, Inc.